Companion Diagnostics Market by Product & Service (Assay, Kit, Software & Service), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung & Gastric Cancer, Neurological Disease), End-User (Pharma Companies, CRO), Region - Global Forecast to 2025

Abstract
Apex Market Research has published a new report titled ”Global Companion Diagnostics Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global Companion Diagnostics market is estimated to grow from USD 3.7 billion in 2020 to USD 6.8 billion by 2025, at a CAGR of 12.9%. The report offers in-depth insights, revenue details, and other vital information regarding the global Companion Diagnostics market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the Companion Diagnostics market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global Companion Diagnostics market report offers in-depth insights, revenue details, and other vital information regarding the global Companion Diagnostics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of Companion Diagnostics market. The major players operating into Companion Diagnostics Market include: F. Hoffmann-La Roche AG (Switzerland)
Agilent Technologies
Inc. (US)
QIAGEN N.V. (Germany)
Abbott Laboratories
Inc. (US)
Almac Group (UK)
Danaher Corporation (US)
Illumina
Inc. (US)
bioMrieux SA (France)
Myriad Genetics
Inc.
(US)
Sysmex Corporation (Japan)
Thermo Fisher Scientific Inc. (US)
Abnova Corporation (Taiwan)
Guardant Health
Inc. (US)
Icon Plc (Ireland)
Biogenex Laboratories
Inc. (US) Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value Value (USD Million)
Covered Segments Products and Services, Technology, Indication, End User
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the Companion Diagnostics market to forecast revenues and analyze trends in each of the following submarkets:

Companion diagnostics Market, by Product & Service

  • Assay kits & Reagents
  • Software & Services

Companion diagnostics Market, by Technology

  • Polymerase Chain Reaction (PCR) 
  • In Situ Hybridization (ISH) 
  • Next-Generation Sequencing (NGS)
  • Immunohistochemistry (IHC) 
  • Others (Multiplex Assay and Cellular Imaging Technologies)

Companion diagnostics Market, by Indication

  • Cardiovascular
  • Neurological Diseases
  • Cancer
    • Breast Cancer 
    • Lung Cancer 
    • Colorectal Cancer 
    • Melanoma 
    • Gastric Cancer 
  • Infectious Diseases 
  • Others (inflammatory and inherited diseases)

Companion diagnostics Market, by End User

  • Pharmaceutical & Biopharmaceutical Companies
  • Reference Laboratories
  • CROs
  • Others (Physicians, Hospitals, Academic Medical Centers, Payers)
By geography, this market has been segregated into five regions with revenue and growth rate of Companion Diagnostics from 2020 to 2027,
There are 13 chapters to put on view for Companion Diagnostics Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Companion Diagnostics Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Companion Diagnostics Market Overview 1.1.1 Companion Diagnostics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Companion Diagnostics Market Size and Analysis by Regions (2015-2019) 1.2.1 North America Companion Diagnostics Market Status and Outlook 1.2.2 EU Companion Diagnostics Market Status and Outlook 1.2.3 Japan Companion Diagnostics Market Status and Outlook 1.2.4 China Companion Diagnostics Market Status and Outlook 1.2.5 India Companion Diagnostics Market Status and Outlook 1.2.6 Southeast Asia Companion Diagnostics Market Status and Outlook 1.3 Global Companion Diagnostics Market Segment Companion diagnostics Market, by Product & Service
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.1 Assay kits & Reagents
1.3.1.1 Market Estimates And Forecast By Country, 2015-2027
1.3.2 Software & Services
1.3.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4 Global Companion Diagnostics Market Segment Companion diagnostics Market, by Technology
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.1 Polymerase Chain Reaction (PCR) 
1.4.1.1 Market Estimates And Forecast By Country, 2015-2027
1.4.2 In Situ Hybridization (ISH) 
1.4.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4.3 Next-Generation Sequencing (NGS)
1.4.3.1 Market Estimates And Forecast By Country, 2015-2027
1.4.4 Immunohistochemistry (IHC) 
1.4.4.1 Market Estimates And Forecast By Country, 2015-2027
1.4.5 Others (Multiplex Assay and Cellular Imaging Technologies)
1.4.5.1 Market Estimates And Forecast By Country, 2015-2027
1.5 Global Companion Diagnostics Market Segment Companion diagnostics Market, by Indication
1.5.1 Introduction
1.5.1.1 Market Estimates And Forecast 2015-2027
1.5.1 Cardiovascular
1.5.1.1 Market Estimates And Forecast By Country, 2015-2027
1.5.2 Neurological Diseases
1.5.2.1 Market Estimates And Forecast By Country, 2015-2027
1.5.2 Cancer
1.5.2.1 Breast Cancer 
1.5.2.2 Lung Cancer 
1.5.2.3 Colorectal Cancer 
1.5.2.4 Melanoma 
1.5.2.5 Gastric Cancer 
1.5.2.6 Market Estimates And Forecast By Country, 2015-2027
1.5.2.5 Infectious Diseases 
1.5.2.6 Market Estimates And Forecast By Country, 2015-2027
1.5.2.5 Others (inflammatory and inherited diseases)
1.5.2.6 Market Estimates And Forecast By Country, 2015-2027
1.6 Global Companion Diagnostics Market Segment Companion diagnostics Market, by End User
1.6.1 Introduction
1.6.1.1 Market Estimates And Forecast 2015-2027
1.6.1 Pharmaceutical & Biopharmaceutical Companies
1.6.1.1 Market Estimates And Forecast By Country, 2015-2027
1.6.2 Reference Laboratories
1.6.2.1 Market Estimates And Forecast By Country, 2015-2027
1.6.3 CROs
1.6.3.1 Market Estimates And Forecast By Country, 2015-2027
1.6.4 Others (Physicians, Hospitals, Academic Medical Centers, Payers)
1.6.4.1 Market Estimates And Forecast By Country, 2015-2027
1.6.5
1.6.5.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global Companion Diagnostics Competition Analysis by Players 2.1 Global Companion Diagnostics Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 F. Hoffmann-La Roche AG (Switzerland) 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Hoffmann-La Roche AG (Switzerland), Companion Diagnostics Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 Agilent Technologies 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Agilent Technologies, Companion Diagnostics Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 Inc. (US) 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Inc. (US), Companion Diagnostics Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 QIAGEN N.V. (Germany) 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 QIAGEN N.V. (Germany), Companion Diagnostics Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 Abbott Laboratories 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Abbott Laboratories, Companion Diagnostics Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 Inc. (US) 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Inc. (US), Companion Diagnostics Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 Almac Group (UK) 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Almac Group (UK), Companion Diagnostics Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 Danaher Corporation (US) 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Danaher Corporation (US), Companion Diagnostics Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 Illumina 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Illumina, Companion Diagnostics Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 Inc. (US) 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Inc. (US), Companion Diagnostics Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global Companion Diagnostics Market Size Type (2015-2019) 4.1 Global Companion Diagnostics Market Size by Type (2015-2019) Chapter 5 Global Companion Diagnostics Market Size Application (2015-2019) 5.1 Global Companion Diagnostics Market Size by Application (2015-2019) 5.2 Potential Application of Companion Diagnostics in Future 5.3 Top Consumer / End Users of Companion Diagnostics Chapter 6 North America Companion Diagnostics Development Status and Outlook 6.1 North America Companion Diagnostics Market Size (2015-2019) 6.2 North America Companion Diagnostics Market Size by Application (2015-2019) Chapter 7 EU Companion Diagnostics Development Status and Outlook 7.1 EU Companion Diagnostics Market Size (2015-2019) 7.2 EU Companion Diagnostics Market Size by Application (2015-2019) Chapter 8 Japan Companion Diagnostics Development Status and Outlook 8.1 Japan Companion Diagnostics Market Size (2015-2019) 8.2 Japan Companion Diagnostics Market Size by Application (2015-2019) Chapter 9 China Companion Diagnostics Development Status and Outlook 9.1 China Companion Diagnostics Market Size and Forecast (2015-2019) 9.2 China Companion Diagnostics Market Size by Application (2015-2019) Chapter 10 India Companion Diagnostics Development Status and Outlook 10.1 India Companion Diagnostics Market Size and Forecast (2015-2019) 10.2 India Companion Diagnostics Market Size by Application (2015-2019) Chapter 11 Southeast Asia Companion Diagnostics Development Status and Outlook 11.1 Southeast Asia Companion Diagnostics Market Size and Forecast (2015-2019) 11.2 Southeast Asia Companion Diagnostics Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global Companion Diagnostics Market Size (Million USD) by Regions (2020-2027) 12.1. North America Companion Diagnostics Revenue and Growth Rate (2020-2027) 12.1.2 EU Companion Diagnostics Revenue and Growth Rate (2020-2027) 12.1.3 China Companion Diagnostics Revenue and Growth Rate (2020-2027) 12.1.4 Japan Companion Diagnostics Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia Companion Diagnostics Revenue and Growth Rate (2020-2027) 12.1.6 India Companion Diagnostics Revenue and Growth Rate (2020-2027) 12.2 Global Companion Diagnostics Market Size by Application (2020-2027) Chapter 13 Companion Diagnostics Market Dynamics 13.1 Companion Diagnostics Market Opportunities 13.2 Companion Diagnostics Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Companion Diagnostics Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Companion Diagnostics Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
1270

8743

OUR CLIENT